Cisplatin versus carboplatin for the treatment of limited-stage small cell lung cancer (LS-SCLC).

8565Background: Standard of care therapy for LS- SCLC is concurrent chemo-radiation (CRT) with a platinum-etoposide backbone. Cisplatin is traditionally the preferred platinum agent in the curative...